Press releases
- NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
- NanoVibronix Issues Letter to Stockholders
- NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
- NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
Key statistics
On Friday, Nanovibronix Inc (56R0:STU) closed at 0.65, 4.00% above its 52-week low of 0.625, set on Jul 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.65 |
---|---|
High | 0.65 |
Low | 0.65 |
Bid | 0.625 |
Offer | 0.705 |
Previous close | 0.65 |
Average volume | 0.00 |
---|---|
Shares outstanding | 2.78m |
Free float | 2.77m |
P/E (TTM) | -- |
Market cap | 2.00m USD |
EPS (TTM) | -1.72 USD |
Data delayed at least 15 minutes, as of Jul 05 2024.
More ▼